Understanding the mechanisms of congenital hydrocephalus using genomic sequencing approaches
使用基因组测序方法了解先天性脑积水的机制
基本信息
- 批准号:10789333
- 负责人:
- 金额:$ 39.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-11 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:Abnormal CellAccelerationAffectAlabamaBiologicalBiomedical ResearchBrainCellsCerebral VentriclesCerebrospinal FluidChildClinicalCongenital HydrocephalusDataDevelopmentDiseaseEtiologyFailureFamilyGenesGeneticGenetic VariationGenomic approachGenomicsGerm-Line MutationGoalsHealthHealthcare SystemsHemorrhageHeterogeneityHumanHydrocephalusIndividualInfectionInfrastructureKnowledgeLifeLinkLive BirthMethodsMissionMolecularMutationNeuronal PlasticityNeuronsNormal tissue morphologyNucleic Acid Regulatory SequencesOperative Surgical ProceduresOutcomePatientsPhenotypePlayPrevalencePreventionProceduresPublic HealthResearchResourcesRoleSamplingSomatic MutationSwabTechnologyTestingTissue SampleTissuesUnited States National Institutes of HealthVariantVentriculostomyWorkaccurate diagnosisbiobankbrain tissuecell typeeffective interventioneffective therapyexome sequencinggenome sequencinggenomic toolsimprovedinnovationinsertion/deletion mutationinsightmultiple omicsnovelpersonalized interventionphenomicssingle cell analysissingle cell sequencingtoolwhole genome
项目摘要
Congenital Hydrocephalus (CH) is a condition that affects the brain and results from an abnormal accumulation
of cerebrospinal fluid (CSF) within the cerebral ventricles. The current treatments for hydrocephalus are surgical
interventions, which accompanies a high failure rate. Although extrinsic factors such as hemorrhage or infections
may cause CH, recent studies have identified some CH-associated genes or mutations, emphasizing the role of
genetics in CH. However, these genetic factors only account for approximately 22% of sporadic CH cases, and
many cases remain unsolved. Therefore, there is an urgent need to accelerate the understanding of CH through
the cutting-edge technologies. Without leveraging these novel methods, the discovery of additional causal
genetic factors of CH and the advancement of accurate diagnoses and treatments may be hindered. The long-
term goal is to understand the molecular mechanisms and consequences underlying CH using orthogonal
phenomic, genetic, and multi-omics approaches. The overall objective is to develop and apply new genomics
tools to advance our understanding of the biological mechanisms of CH. The central hypothesis is that there are
additional genetic variations in germline or somatic and/or specific malfunctioning cell types that contribute to
the etiology of CH. To test this hypothesis, the PIs and team will pursue the following aims. 1) Comprehensive
characterization of all forms of variations in both germline and somatic tissue from CH patients with short- and
long- read whole genome sequencing. 2) Identification of abnormal cell types and understanding their function
and contribution to CH through single-cell genomics analysis. Upon completion, it is expected that new variations
either in the germline or somatic may contribute to CH.
先天性脑积水 (CH) 是一种影响大脑的疾病,是由异常积水引起的
脑室内的脑脊液(CSF)。目前脑积水的治疗方法是手术
干预措施,但失败率很高。尽管出血或感染等外在因素
可能会导致CH,最近的研究已经确定了一些CH相关基因或突变,强调了CH的作用
CH 中的遗传学。然而,这些遗传因素仅占散发性慢性肝炎病例的约 22%,并且
许多案件仍未解决。因此,迫切需要通过以下方式加速对CH的理解:
尖端技术。如果不利用这些新方法,就会发现额外的因果关系
CH的遗传因素以及准确诊断和治疗的进展可能会受到阻碍。长-
术语目标是使用正交法了解 CH 的分子机制和后果
表组学、遗传学和多组学方法。总体目标是开发和应用新的基因组学
增进我们对 CH 生物学机制的理解的工具。中心假设是有
种系或体细胞和/或特定功能障碍细胞类型的额外遗传变异有助于
CH 的病因学。为了检验这一假设,PI 和团队将追求以下目标。 1)综合性
对 CH 患者的种系和体细胞组织中所有形式的变异进行表征
长读长全基因组测序。 2) 识别异常细胞类型并了解其功能
以及通过单细胞基因组学分析对 CH 的贡献。完成后,预计会有新的变化
种系或体细胞都可能导致 CH。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zechen Chong其他文献
Zechen Chong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zechen Chong', 18)}}的其他基金
Structural variation analysis with and without a reference genome
有和没有参考基因组的结构变异分析
- 批准号:
10655596 - 财政年份:2020
- 资助金额:
$ 39.29万 - 项目类别:
Structural variation analysis with and without a reference genome
有和没有参考基因组的结构变异分析
- 批准号:
10029410 - 财政年份:2020
- 资助金额:
$ 39.29万 - 项目类别:
Structural variation analysis with and without a reference genome
有和没有参考基因组的结构变异分析
- 批准号:
10212425 - 财政年份:2020
- 资助金额:
$ 39.29万 - 项目类别:
Structural variation analysis with and without a reference genome
有和没有参考基因组的结构变异分析
- 批准号:
10436328 - 财政年份:2020
- 资助金额:
$ 39.29万 - 项目类别:
相似国自然基金
高功率激光驱动低β磁重联中磁岛对电子加速影响的研究
- 批准号:12305275
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
食欲素2型受体通过影响BACE2功能增加脑内Aβ产生加速阿尔茨海默病发生发展的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
PRAS40通过促进G6PI/PGK1/LDHA复合物的组装加速糖酵解进程对结直肠癌发生的影响及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
流相互作用区对太阳高能粒子加速和传输过程的影响
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
下游边界对磁重联出流区电子加速的影响
- 批准号:
- 批准年份:2019
- 资助金额:63 万元
- 项目类别:面上项目
相似海外基金
Elucidation of contributions of telomere damage and non-cell autonomy to the pathophysiology of Friedreich ataxia using a zebrafish model
使用斑马鱼模型阐明端粒损伤和非细胞自主性对弗里德赖希共济失调病理生理学的贡献
- 批准号:
10723485 - 财政年份:2023
- 资助金额:
$ 39.29万 - 项目类别:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
- 批准号:
10683443 - 财政年份:2023
- 资助金额:
$ 39.29万 - 项目类别:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
- 批准号:
10683443 - 财政年份:2023
- 资助金额:
$ 39.29万 - 项目类别:
Renal endothelium and the development of chronic kidney disease in sickle cell disorders
镰状细胞病中的肾内皮和慢性肾病的发展
- 批准号:
10659575 - 财政年份:2023
- 资助金额:
$ 39.29万 - 项目类别: